Clinical trial

A Study for Patients With Diabetes Mellitus (IOPA)

NCT00420095 · Eli Lilly and Company, Industry · Completed

Key facts

NCT number NCT00420095
Title A Study for Patients With Diabetes Mellitus (IOPA)
Official title Comparison of HbA1c in Type 1 or Type 2 Diabetic Patients Using Insulin Treated Twice Daily With Either Insulin Lispro Low Mixture or Human Insulin Mix 30/70
Acronym IOPA
Lead sponsor Eli Lilly and Company, Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Diabetes Mellitus, Type 1, Type 2
Intervention type Drug
Interventions Human insulin 30/70, Insulin lispro low mix
Enrollment 117
Start date Jan 1, 2007
Primary completion Jan 1, 2008
Completion Jan 1, 2008
First posted Jan 9, 2007
Last update posted Jun 17, 2009
Countries China

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies